Study of 2.5 million children finds no link between MMR vaccine and autism
A new study of over 2.5 million children provides evidence that receiving the measles, mumps, and rubella vaccine before age two is not associated with an increased risk of developing autism. The findings, published in The Pediatric Infectious Disease Journal, indicate that the precise timing of the immunization was not linked to a child’s likelihood of being diagnosed with the developmental condition.
Autism spectrum disorder is a developmental condition that affects how a person communicates, interacts with others, and experiences the world. The condition is currently estimated to affect about 3.2 percent of children in the United States. The measles, mumps, and rubella vaccine is a standard early childhood immunization that protects against three highly contagious and potentially severe viral infections.
Fears linking this routine vaccine to autism persist among some parents, frequently leading to delayed or declined immunizations. This anxiety largely stems from a 1998 case series, a report on just 12 children, that was later retracted due to scientific misconduct. Numerous large studies over the years have found no link between the vaccine and the developmental condition.
Even with this extensive body of research, observational studies on vaccine safety face built-in design challenges. Factors like a family’s healthcare habits, early parental concerns about a child’s development, and the child’s age can influence both when they get vaccinated and if they receive an autism diagnosis.
If an analysis does not adjust for the fact that children receive vaccines at different developmental stages, the results might be skewed. The research, led by Todd L. Burstain of UW Medicine, aimed to address these complexities using a more precise study design.
The authors utilized an approach known as age-anchored landmark analysis. This method groups children by the age window in which a vaccination decision is typically made, comparing vaccinated and unvaccinated children within those defined age windows to reduce bias.
To carry out the research, the scientists analyzed records from Cosmos, a massive electronic health record database spanning hospitals and clinics across the United States. The dataset included 2,560,035 children who had at least one routine primary care visit between 12 and 24 months of age. The prevalence of childhood autism in this sample was 2.55 percent. The researchers focused on a specific diagnostic code for childhood autism, a narrower category than the full autism spectrum, which partly explains why the prevalence in the sample was lower than the national estimate.
https://www.psypost.org/study-of-2-5-million-children-finds-no-link-between-mmr-vaccine-and-autism/